CUE - Cue Biopharma EPS beats by $0.03 misses on revenue March, 16 2021 04:56 PM Cue Biopharma Inc. Cue Biopharma (CUE): Q4 GAAP EPS of -$0.37 beats by $0.03.Revenue of $0.46M (-56.2% Y/Y) misses by $0.61M.Press Release For further details see: Cue Biopharma EPS beats by $0.03, misses on revenue